{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:56:59Z","timestamp":1740149819431,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T00:00:00Z","timestamp":1657756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"JSPS KAKENHI Grant","award":["20K08312"],"award-info":[{"award-number":["20K08312"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s12328-022-01669-7","type":"journal-article","created":{"date-parts":[[2022,7,14]],"date-time":"2022-07-14T15:04:59Z","timestamp":1657811099000},"page":"960-967","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A case of hepatocellular carcinoma with long-term survival by multidisciplinary treatment for cranial and skeletal muscle metastases"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4673-3333","authenticated-orcid":false,"given":"Noriyuki","family":"Akutsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujiro","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunao","family":"Numata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Wagatsuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Ishigami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Nakase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,14]]},"reference":[{"key":"1669_CR1","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380:1450\u201362.","journal-title":"N Engl J Med"},{"key":"1669_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6.","journal-title":"Nat Rev Dis Primers"},{"key":"1669_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s12029-017-9998-6","volume":"48","author":"R Bhatia","year":"2017","unstructured":"Bhatia R, Ravulapati S, Befeler A, et al. Hepatocellular carcinoma with bone metastases: incidence, prognostic significance, and management-single-center experience. J Gastrointest Cancer. 2017;48:321\u20135.","journal-title":"J Gastrointest Cancer"},{"key":"1669_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"G D'Amico","year":"2006","unstructured":"D\u2019Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217\u201331.","journal-title":"J Hepatol"},{"key":"1669_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000479984","volume":"6","author":"A Hiraoka","year":"2017","unstructured":"Hiraoka A, Michitaka K, Kumada T, et al. Validation and potential of albumin-bilirubin grade and prognostication in a nationwide survey of 46,681 hepatocellular carcinoma patients in Japan: the need for a more detailed evaluation of hepatic function. Liver Cancer. 2017;6:325\u201336.","journal-title":"Liver Cancer"},{"key":"1669_CR6","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/00042737-200109000-00015","volume":"13","author":"M Fukutomi","year":"2001","unstructured":"Fukutomi M, Yokota M, Chuman H, et al. Increased incidence of bone metastases in hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2001;13:1083\u20138.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1669_CR7","first-page":"447","volume":"49","author":"JI McIver","year":"2001","unstructured":"McIver JI, Scheithauer BW, Rydberg CH, et al. Metastatic hepatocellular carcinoma presenting as epidural hematoma: case report. Neurosurgery. 2001;49:447\u20139.","journal-title":"Neurosurgery"},{"key":"1669_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4251\/wjgo.v2.i3.165","volume":"2","author":"T Goto","year":"2010","unstructured":"Goto T, Dohmen T, Miura K, et al. Skull metastasis from hepatocellular carcinoma with chronic hepatitis B. World J Gastrointest Oncol. 2010;2:165\u20138.","journal-title":"World J Gastrointest Oncol"},{"key":"1669_CR9","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00701-006-1071-3","volume":"149","author":"CT Hsieh","year":"2007","unstructured":"Hsieh CT, Sun JM, Tsai WC, et al. Skull metastasis from hepatocellular carcinoma. Acta Neurochir (Wien). 2007;149:185\u201390.","journal-title":"Acta Neurochir (Wien)"},{"key":"1669_CR10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3892\/ol.2015.3947","volume":"11","author":"YS Kim","year":"2016","unstructured":"Kim YS, Moon KS, Lee KH, et al. Spontaneous acute epidural hematoma developed due to skull metastasis of hepatocelluar carcinoma: a case report and review of the literature. Oncol Lett. 2016;11:741\u20134.","journal-title":"Oncol Lett"},{"key":"1669_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12893-015-0045-x","volume":"15","author":"CL Chye","year":"2015","unstructured":"Chye CL, Lin KH, Ou CH, et al. Acute spontaneous subdural hematoma caused by skull metastasis of hepatocellular carcinoma: case report. BMC Surg. 2015;15:60.","journal-title":"BMC Surg"},{"key":"1669_CR12","first-page":"5945726","volume":"2019","author":"KW Sadik","year":"2019","unstructured":"Sadik KW, Dayoub H, Bonatti H. Superior sagittal sinus tumor eroding through the skull: an unfamiliar presentation of hepatocellular carcinoma and literature review. Case Rep Surg. 2019;2019:5945726.","journal-title":"Case Rep Surg"},{"issue":"61\u20136","key":"1669_CR13","first-page":"vi","volume":"22","author":"RB Chamoun","year":"2011","unstructured":"Chamoun RB, DeMonte F. Management of skull base metastases. Neurosurg Clin N Am. 2011;22(61\u20136):vi\u2013ii.","journal-title":"Neurosurg Clin N Am"},{"key":"1669_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0090-3019(03)00269-6","volume":"60","author":"AM Stark","year":"2003","unstructured":"Stark AM, Eichmann T, Mehdorn HM. Skull metastases: clinical features, differential diagnosis, and review of the literature. Surg Neurol. 2003;60:219\u201325 (discussion 25-6).","journal-title":"Surg Neurol"},{"key":"1669_CR15","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1468-1331.2006.01506.x","volume":"13","author":"R Soffietti","year":"2006","unstructured":"Soffietti R, Cornu P, Delattre JY, et al. EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol. 2006;13:674\u201381.","journal-title":"Eur J Neurol"},{"key":"1669_CR16","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1001\/jama.280.17.1485","volume":"280","author":"RA Patchell","year":"1998","unstructured":"Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998;280:1485\u20139.","journal-title":"JAMA"},{"key":"1669_CR17","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/s00595-005-3141-1","volume":"36","author":"MH Wu","year":"2006","unstructured":"Wu MH, Wu YM, Lee PH. The psoas muscle as an unusual site for metastasis of hepatocellular carcinoma: report of a case. Surg Today. 2006;36:280\u20132.","journal-title":"Surg Today"},{"key":"1669_CR18","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1477-7819-6-42","volume":"6","author":"T Yau","year":"2008","unstructured":"Yau T, Wong H, Chan P, et al. Intramuscular recurrence in a hepatocellular carcinoma patient with indolent disease course. World J Surg Oncol. 2008;6:42.","journal-title":"World J Surg Oncol"},{"key":"1669_CR19","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1111\/j.1440-1746.2009.05962.x","volume":"24","author":"T Sano","year":"2009","unstructured":"Sano T, Izuishi K, Takebayashi R, et al. Education and imaging hepatobiliary and pancreatic: isolated diaphragmatic metastasis from hepatocellular carcinoma. J Gastroenterol Hepatol. 2009;24:1475.","journal-title":"J Gastroenterol Hepatol"},{"key":"1669_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jus.2008.12.005","volume":"12","author":"D Sirigu","year":"2009","unstructured":"Sirigu D, Loi L, Mura R, et al. Muscle metastasis from hepatocellular carcinoma in a patient treated with TACE. J Ultrasound. 2009;12:45\u20137.","journal-title":"J Ultrasound"},{"key":"1669_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.4103\/0973-1482.80467","volume":"7","author":"V Michalaki","year":"2011","unstructured":"Michalaki V, Zygogianni A, Kouloulias V, et al. Muscle metastasis from hepatocellular carcinoma. J Cancer Res Ther. 2011;7:81\u20133.","journal-title":"J Cancer Res Ther"},{"key":"1669_CR22","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ijscr.2012.04.003","volume":"3","author":"K Furumoto","year":"2012","unstructured":"Furumoto K, Miura K, Nagashima D, et al. Solitary metastasis to the intercostal muscle from hepatocellular carcinoma: a case report. Int J Surg Case Rep. 2012;3:322\u20136.","journal-title":"Int J Surg Case Rep"},{"key":"1669_CR23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1258\/arsr.2011.110002","volume":"1","author":"H Jiang","year":"2012","unstructured":"Jiang H, Wang Z, Xian J, et al. Bilateral multiple extraocular muscle metastasis from hepatocellular carcinoma. Acta Radiol Short Rep. 2012;1:1\u20133.","journal-title":"Acta Radiol Short Rep"},{"key":"1669_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.3857\/roj.2013.31.4.267","volume":"31","author":"S Jo","year":"2013","unstructured":"Jo S, Shim HK. A patient who has survived for a long period with repeated radiotherapies for multifocal extrahepatic metastases from hepatocellular carcinoma. Radiat Oncol J. 2013;31:267\u201372.","journal-title":"Radiat Oncol J"},{"key":"1669_CR25","doi-asserted-by":"publisher","first-page":"bcr2013200437","DOI":"10.1136\/bcr-2013-200437","volume":"2013","author":"N Subramaniam","year":"2013","unstructured":"Subramaniam N, Hiremath B, Pujar A. Metastasis of diffuse hepatocellular carcinoma to an extremely unusual site. BMJ Case Rep. 2013;2013:bcr2013200437.","journal-title":"BMJ Case Rep"},{"key":"1669_CR26","first-page":"E65","volume":"5","author":"D Traficante","year":"2014","unstructured":"Traficante D, Assalone P, Tomei F, et al. A case report of HCC cutaneous metastasis. J Gastrointest Oncol. 2014;5:E65\u20137.","journal-title":"J Gastrointest Oncol"},{"key":"1669_CR27","doi-asserted-by":"crossref","first-page":"205846011771670","DOI":"10.1177\/2058460117716705","volume":"6","author":"EA Rahim","year":"2017","unstructured":"Rahim EA, Noh MS, Ngah NA, et al. Hepatocellular carcinoma with disseminated skeletal muscle metastasis. Acta Radiol Open. 2017;6:2058460117716705.","journal-title":"Acta Radiol Open"},{"key":"1669_CR28","doi-asserted-by":"publisher","first-page":"973","DOI":"10.4254\/wjh.v9.i22.973","volume":"9","author":"K Takahashi","year":"2017","unstructured":"Takahashi K, Putchakayala KG, Safwan M, et al. Extrahepatic metastasis of hepatocellular carcinoma to the paravertebral muscle: a case report. World J Hepatol. 2017;9:973\u20138.","journal-title":"World J Hepatol"},{"key":"1669_CR29","doi-asserted-by":"publisher","first-page":"306","DOI":"10.12659\/AJCR.913730","volume":"20","author":"K Orita","year":"2019","unstructured":"Orita K, Sakamoto A, Okamoto T, et al. Solitary muscle metastasis of hepatocellular carcinoma to the biceps femoris muscle with only elevated serum PIVKA-II: a case report. Am J Case Rep. 2019;20:306\u20139.","journal-title":"Am J Case Rep"},{"key":"1669_CR30","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.7200-21","author":"A Nakayama","year":"2021","unstructured":"Nakayama A, Arai J, Otoyama Y, et al. Muscular metastasis of hepatocellular carcinoma: case report and literature review. Intern Med (Tokyo, Japan). 2021. https:\/\/doi.org\/10.2169\/internalmedicine.7200-21.","journal-title":"Intern Med (Tokyo, Japan)"},{"key":"1669_CR31","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.12998\/wjcc.v9.i14.3334","volume":"9","author":"Q Song","year":"2021","unstructured":"Song Q, Sun XF, Wu XL, et al. Skeletal muscle metastases of hepatocellular carcinoma: a case report and literature review. World J Clin Cases. 2021;9:3334\u201341.","journal-title":"World J Clin Cases"},{"key":"1669_CR32","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3349\/ymj.2013.54.5.1178","volume":"54","author":"J Cha","year":"2013","unstructured":"Cha J, Seong J, Lee IJ, et al. Feasibility of sorafenib combined with local radiotherapy in advanced hepatocellular carcinoma. Yonsei Med J. 2013;54:1178\u201385.","journal-title":"Yonsei Med J"},{"key":"1669_CR33","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.12659\/MSM.913470","volume":"25","author":"X Guo","year":"2019","unstructured":"Guo X, Xu Y, Wang X, et al. Advanced hepatocellular carcinoma with bone metastases: prevalence, associated factors, and survival estimation. Med Sci Monit. 2019;25:1105\u201312.","journal-title":"Med Sci Monit"},{"key":"1669_CR34","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","volume":"6","author":"R Phillips","year":"2020","unstructured":"Phillips R, Shi WY, Deek M, et al. Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial. JAMA Oncol. 2020;6:650\u20139.","journal-title":"JAMA Oncol"},{"key":"1669_CR35","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","volume":"393","author":"DA Palma","year":"2019","unstructured":"Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet (London, England). 2019;393:2051\u20138.","journal-title":"Lancet (London, England)"},{"key":"1669_CR36","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","volume":"17","author":"DR Gomez","year":"2016","unstructured":"Gomez DR, Blumenschein GR Jr, Lee JJ, et al. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 2016;17:1672\u201382.","journal-title":"Lancet Oncol"},{"key":"1669_CR37","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s00432-021-03553-2","volume":"147","author":"TH Kim","year":"2021","unstructured":"Kim TH, Park S, Rim CH, et al. Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma. J Cancer Res Clin Oncol. 2021;147:2693\u2013700.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1669_CR38","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000514174","volume":"10","author":"M Kudo","year":"2021","unstructured":"Kudo M, Kawamura Y, Hasegawa K, et al. Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update. Liver Cancer. 2021;10:181\u2013223.","journal-title":"Liver Cancer"},{"key":"1669_CR39","first-page":"10495","volume":"10","author":"K Jin","year":"2017","unstructured":"Jin K, Lan H, Wang X, et al. Genetic heterogeneity in hepatocellular carcinoma and paired bone metastasis revealed by next-generation sequencing. Int J Clin Exp Pathol. 2017;10:10495\u2013504.","journal-title":"Int J Clin Exp Pathol"},{"key":"1669_CR40","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","volume":"382","author":"RS Finn","year":"2020","unstructured":"Finn RS, Qin S, Ikeda M, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020;382:1894\u2013905.","journal-title":"N Engl J Med"},{"key":"1669_CR41","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","volume":"391","author":"M Kudo","year":"2018","unstructured":"Kudo M, Finn RS, Qin S, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet (London, England). 2018;391:1163\u201373.","journal-title":"Lancet (London, England)"},{"key":"1669_CR42","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S0140-6736(16)32453-9","volume":"389","author":"J Bruix","year":"2017","unstructured":"Bruix J, Qin S, Merle P, et al. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet (London, England). 2017;389:56\u201366.","journal-title":"Lancet (London, England)"},{"key":"1669_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30165-2","volume":"20","author":"AX Zhu","year":"2019","unstructured":"Zhu AX, Finn RS, Galle PR, et al. Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of \u03b1-fetoprotein. Lancet Oncol. 2019;20: e191.","journal-title":"Lancet Oncol"},{"key":"1669_CR44","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMoa1717002","volume":"379","author":"GK Abou-Alfa","year":"2018","unstructured":"Abou-Alfa GK, Meyer T, Cheng AL, et al. Cabozantinib in patients with advanced and progressing hepatocellular carcinoma. N Engl J Med. 2018;379:54\u201363.","journal-title":"N Engl J Med"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-022-01669-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-022-01669-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-022-01669-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T15:36:09Z","timestamp":1700840169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-022-01669-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,14]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["1669"],"URL":"https:\/\/doi.org\/10.1007\/s12328-022-01669-7","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2022,7,14]]},"assertion":[{"value":"12 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human\/animal rights"}},{"value":"Informed consent was obtained from the spouse of the patient for being included in the present report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}